More on OA
Osteoarthritis [OA] is a musculoskeletal disorder with pain as the most dominant symptom, followed by limitation of movement or even disability and structural deformation of the joints. Women are being more frequently affected than men, especially in persons over 50 years of age. Important risk factors are obesity, inflammation, previous traumatic injury and muscular weakness.
At present both in humans and companion animals neither good diagnostic tools nor effective treatments are available.
Orthros Medical and the research groups of its founders have developed a new approach to detect OA [Orthros partner QVQ] and to slow down or even cure OA using Llama antibodies [VHH] directed to important factors in OA, in particular factors involved in pain generation and inflammation.
Whereas VHH are very important in the routes Orthros develops, it is also essential that these VHH remain exactly at the place to be treated for a considerable time. To obtain this goal Orthros works together with IAMFluidics, Hy2Care and Innocore.
Another characteristic of the Orthros approach is that we focus on OA factors that are highly homologous between humans and companion animals. Therefore Orthros works closely together with UU Faculty of Veterinary Medicine